ProQR Therapeutics
PRQR

股本结构

单位：万股
公告日期 2025-11-06 2025-05-08 2025-03-13 2024-10-25 2024-10-24 2024-11-07
证券总股本 10534.52 10771.09 10521.25 10320.37 9968.02 8168.34
普通股本 10534.52 10771.09 10521.25 10320.37 9968.02 8168.34
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-09-30 2025-01-01 2024-12-31 2024-10-25 2024-10-24 2024-09-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-11-06 10534.52 未披露 定期报告 2025-09-30
2025-05-08 10771.09 未披露 定期报告 2025-01-01
2025-03-13 10521.25 未披露 定期报告 2024-12-31
2024-10-25 10320.37 未披露
更多>>
The Company agreed to offer and sell to Lilly, and Lilly has agreed to purchase, 3,523,538 ordinary shares of the Company at a price per share equal to the Public Offering Price.
2024-10-25
2024-10-24 9968.02 未披露
更多>>
Ordinary shares offered 18,000,000 shares by the company
2024-10-24
2024-11-07 8168.34 未披露
更多>>
From January 1, 2024 to September 30, 2024 Treasury shares transferred Share options exercised / RSUs vested
2024-09-30
2024-09-30 8168.02 未披露 定期报告 2024-06-30
2024-05-09 8424.84 未披露 定期报告 2024-03-31
2024-03-13 8135.46 未披露
更多>>
From January 1,2023 to December 31,2023 Exercise of share options / vesting of RSUs Treasury shares issued (transferred)
2023-12-31
2023-11-07 8115.75 未披露 定期报告 2023-09-30
2023-08-03 8424.70 未披露 定期报告 2023-06-30
2023-05-16 8093.57 未披露 定期报告 2023-03-31
2023-03-29 8081.71 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issue of ordinary shares
2022-12-31
2022-12-23 7143.46 未披露 定期报告 2022-12-21
2022-11-09 7143.38 未披露 定期报告 2022-09-30
2022-05-05 7136.21 未披露
更多>>
From January 1, 2022 to March 31, 2022 Treasury shares transferred Share options exercised / RSUs vested
2022-03-31
2022-04-29 7129.08 未披露
更多>>
From December 31, 2020 to December 31, 2021 Recognition of share-based payments Issuance of ordinary shares Share options exercised
2021-12-31
2021-11-04 7115.46 未披露 定期报告 2021-09-30
2021-08-05 6706.91 未披露
更多>>
From January 1, 2021 to June 30, 2021 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
2021-06-30
2021-04-02 6405.10 未披露
更多>>
1.Ordinary shares offered by the company 13,846,154 shares. 2.The number of ordinary shares expected to be outstanding after this offering and, unless otherwise indicated, the information in this prospectus supplement are based on 50,204,810 ordinary shares outstanding as of December 31, 2020.
2021-04-02
2021-05-06 5108.30 未披露
更多>>
From January 1, 2021 to March 31, 2021 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
2021-03-31
2021-02-25 5020.48 未披露
更多>>
From January 1, 2020 to December 31, 2020 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
2020-12-31
2020-11-16 5014.62 未披露
更多>>
From January 1, 2020 to September 30, 2020 Issuance of ordinary shares Treasury shares transferred Share options exercised
2020-09-30
2020-08-06 5014.27 未披露
更多>>
From January 1, 2020 to June 30, 2020 Recognition of share-based payments Treasury shares transferred Share options exercised
2020-06-30
2020-03-31 4974.57 未披露
更多>>
From December 31, 2018 to December 31, 2019 Recognition of share-based payments Issue of ordinary shares
2019-12-31
2019-10-18 4936.71 未披露 定期报告 2019-10-18
2019-08-07 3891.26 未披露
更多>>
from January 1, 2019 to June 30, 2019 Share options exercised
2019-06-30
2019-05-08 3889.15 未披露
更多>>
from January 1, 2019 to March 31, 2019 Share options exercised
2019-03-31
2019-03-28 3887.29 未披露
更多>>
from December 31, 2017 to December 31, 2018 Recognition of share-based payments Issue of ordinary shares
2018-12-31
2018-11-07 3871.56 未披露
更多>>
from January 1, 2018 to September 30, 2018 Share options exercised
2018-09-30
2018-08-08 3193.46 未披露
更多>>
from January 1, 2018 to June 30, 2018 Share options exercised
2018-06-30
2018-03-30 3192.19 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issue of ordinary shares Issue of treasury shares
2017-12-31
2017-11-20 2546.28 未披露
更多>>
from January 1, 2017 to September 30, 2017 Shares issued in the period Share options exercised
2017-09-30
2017-08-16 2410.52 未披露
更多>>
from January 1, 2017 to June 30, 2017 Shares issued in the period Share options exercised
2017-06-30
2017-05-17 2386.51 未披露
更多>>
from January 1, 2017 to March 31, 2017 Shares issued in the period Share options exercised
2017-03-31
2016-08-17 2334.69 未披露
更多>>
From January 1, 2016 to June 30, 2016 Share options exercised
2016-06-30
2016-03-31 2334.60 未披露
更多>>
from January 1, 2015 to December 31, 2015 Exercise of share options
2015-12-31
2015-11-23 2334.58 未披露
更多>>
from January 1, 2015 to September 30, 2015 Share options exercised
2015-09-30
2015-08-19 2334.34 未披露
更多>>
from January 1, 2015 to June 30, 2015 Share options exercised
2015-06-30
2015-05-21 2334.32 未披露
更多>>
from January 1, 2015 to March 31, 2015 Shares options exercised
2015-03-31
2014-11-24 2333.82 未披露
更多>>
from January 1, 2014 to September 30, 2014 Shares issued in the period Conversion of preferred shares Treasury shares issued All share and per share information in this prospectus gives effect to our capital reorganization effected on September 15, 2014, which had the effect of a 101.804232-for-1 forward split of the ordinary shares;the conversion of all of our outstanding preferred shares into 8,265,179 ordinary shares prior to the completion of this offering
2014-09-30
2014-09-19 2221.32 未披露
更多>>
All share and per share information in this prospectus gives effect to our capital reorganization effected on September 15, 2014, which had the effect of a 101.804232-for-1 forward split of the ordinary shares;the conversion of all of our outstanding preferred shares into 8,265,179 ordinary shares prior to the completion of this offering
2014-09-18
2014-08-14 6.33 8.12 定期报告 2014-06-30
The Company agreed to offer and sell to Lilly, and Lilly has agreed to purchase, 3,523,538 ordinary shares of the Company at a price per share equal to the Public Offering Price.
Ordinary shares offered 18,000,000 shares by the company
From January 1, 2024 to September 30, 2024 Treasury shares transferred Share options exercised / RSUs vested
From January 1,2023 to December 31,2023 Exercise of share options / vesting of RSUs Treasury shares issued (transferred)
From December 31, 2021 to December 31, 2022 Issue of ordinary shares
From January 1, 2022 to March 31, 2022 Treasury shares transferred Share options exercised / RSUs vested
From December 31, 2020 to December 31, 2021 Recognition of share-based payments Issuance of ordinary shares Share options exercised
From January 1, 2021 to June 30, 2021 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
1.Ordinary shares offered by the company 13,846,154 shares. 2.The number of ordinary shares expected to be outstanding after this offering and, unless otherwise indicated, the information in this prospectus supplement are based on 50,204,810 ordinary shares outstanding as of December 31, 2020.
From January 1, 2021 to March 31, 2021 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
From January 1, 2020 to December 31, 2020 Recognition of share-based payments Issuance of ordinary shares Treasury shares transferred Share options exercised
From January 1, 2020 to September 30, 2020 Issuance of ordinary shares Treasury shares transferred Share options exercised
From January 1, 2020 to June 30, 2020 Recognition of share-based payments Treasury shares transferred Share options exercised
From December 31, 2018 to December 31, 2019 Recognition of share-based payments Issue of ordinary shares
from January 1, 2019 to June 30, 2019 Share options exercised
from January 1, 2019 to March 31, 2019 Share options exercised
from December 31, 2017 to December 31, 2018 Recognition of share-based payments Issue of ordinary shares
from January 1, 2018 to September 30, 2018 Share options exercised
from January 1, 2018 to June 30, 2018 Share options exercised
from December 31, 2016 to December 31, 2017 Issue of ordinary shares Issue of treasury shares
from January 1, 2017 to September 30, 2017 Shares issued in the period Share options exercised
from January 1, 2017 to June 30, 2017 Shares issued in the period Share options exercised
from January 1, 2017 to March 31, 2017 Shares issued in the period Share options exercised
From January 1, 2016 to June 30, 2016 Share options exercised
from January 1, 2015 to December 31, 2015 Exercise of share options
from January 1, 2015 to September 30, 2015 Share options exercised
from January 1, 2015 to June 30, 2015 Share options exercised
from January 1, 2015 to March 31, 2015 Shares options exercised
from January 1, 2014 to September 30, 2014 Shares issued in the period Conversion of preferred shares Treasury shares issued All share and per share information in this prospectus gives effect to our capital reorganization effected on September 15, 2014, which had the effect of a 101.804232-for-1 forward split of the ordinary shares;the conversion of all of our outstanding preferred shares into 8,265,179 ordinary shares prior to the completion of this offering
All share and per share information in this prospectus gives effect to our capital reorganization effected on September 15, 2014, which had the effect of a 101.804232-for-1 forward split of the ordinary shares;the conversion of all of our outstanding preferred shares into 8,265,179 ordinary shares prior to the completion of this offering
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。